Tomoyoshi Shibuya Selected Research

Tomoyoshi Shibuya Research Topics

Disease

21	Ulcerative Colitis 05/2024 - 01/2008
10	Neoplasms (Cancer) 04/2022 - 06/2009
8	Hemorrhage 05/2023 - 10/2009
5	Dysbiosis 05/2024 - 01/2017
5	Ulcer 03/2023 - 11/2010
5	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 06/2009
4	Colitis 05/2024 - 11/2010
3	Adenocarcinoma 04/2022 - 10/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 11/2019
2	Disease Progression 03/2024 - 01/2021
2	Collagenous Colitis 12/2023 - 12/2022
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2023 - 05/2014
2	Pathologic Constriction (Stenosis) 03/2023 - 05/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 02/2011
2	Polyps 10/2017 - 03/2017
2	Stomach Neoplasms (Stomach Cancer) 09/2013 - 10/2010
2	Necrosis 01/2012 - 09/2003
2	Inflammation (Inflammations) 06/2011 - 09/2003
2	Duodenal Ulcer (Curling's Ulcer) 06/2011 - 11/2010
1	Hypoxia (Hypoxemia) 03/2024
1	Body Weight (Weight, Body) 03/2024
1	Arteriovenous Malformations (Arteriovenous Malformation) 12/2023
1	Asthma (Bronchial Asthma) 12/2023
1	Constipation 11/2023
1	Crohn Disease (Crohn's Disease) 10/2023
1	Rheumatoid Arthritis 03/2023
1	Abdominal Pain (Pain, Abdominal) 03/2023
1	Ileus 03/2023
1	Peptic Ulcer (Peptic Ulcers) 09/2022
1	Skin Manifestations 06/2022
1	Ovarian Neoplasms (Ovarian Cancer) 04/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022
1	Mesothelioma 04/2022
1	Diarrhea 09/2021
1	Cholangitis 05/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Atrophy 01/2021

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2008
5	Capsules (Microcapsules)IBA 12/2023 - 02/2011
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2023 - 11/2010
4	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 11/2018
4	Fosfomycin FDA Link 01/2022 - 11/2018
4	Amoxicillin (Wymox)FDA LinkGeneric 01/2022 - 11/2018
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022 - 11/2010
2	Dextran SulfateIBA 05/2024 - 03/2024
2	GLPG0634IBA 03/2024 - 12/2023
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2023 - 01/2014
2	vedolizumabIBA 10/2022 - 09/2020
2	Therapeutic UsesIBA 06/2022 - 09/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2020 - 07/2018
2	CytokinesIBA 01/2020 - 02/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 09/2003
1	OxazoloneIBA 05/2024
1	Eukaryotic Translation Initiation Factor 5AIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	Conditioned Culture MediaIBA 03/2024
1	Tyrosine (L-Tyrosine)FDA Link 03/2024
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	Immunoglobulin G (IgG)IBA 03/2024
1	Apoptosis Regulatory ProteinsIBA 03/2024
1	Janus KinasesIBA 03/2024
1	mepolizumabIBA 12/2023
1	SteroidsIBA 12/2023
1	peptide AIBA 05/2023
1	Hemostatics (Antihemorrhagics)IBA 05/2023
1	CollagenIBA 12/2022
1	IntegrinsIBA 10/2022
1	thienopyridineIBA 09/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2022
1	Peptides (Polypeptides)IBA 06/2022
1	MesothelinIBA 04/2022
1	AlginatesIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 11/2021
1	ElectrolytesIBA 09/2021
1	Drinking WaterIBA 01/2021
1	indoleIBA 01/2021
1	HLA-DQ6 antigenIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	GliadinIBA 01/2021
1	AntibodiesIBA 01/2021
1	Nicotine FDA Link 01/2021
1	SolutionsIBA 01/2021
1	anti-transglutaminase autoantibodyIBA 01/2021

Therapy/Procedure

13	Therapeutics 05/2024 - 08/2016
7	Fecal Microbiota Transplantation 05/2024 - 01/2017
3	Endoscopic Hemostasis 05/2023 - 10/2017
3	Traction 11/2014 - 06/2009
3	Surgical Instruments (Clip) 11/2014 - 06/2009
2	Blood Component Removal (Apheresis) 09/2020 - 11/2019
1	Diet Therapy (Therapy, Diet) 11/2023
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2023
1	Donor Selection 02/2022
1	Patient Transfer (Patient Dumping) 01/2022
1	Liver Transplantation 11/2021
1	Stents 05/2021
1	Self Expandable Metallic Stents 05/2021
1	Gluten-Free Diet 01/2021
1	Oral Administration 01/2021